Advertisement

Annals of Surgical Oncology

, Volume 22, Issue 8, pp 2509–2516 | Cite as

A Patient-Centered Approach to Wait Times in the Surgical Management of Breast Cancer in the Province of Ontario

  • Erin Cordeiro
  • Matthew Dixon
  • Natalie Coburn
  • Claire M. B. Holloway
Breast Oncology

Abstract

Background

Wait time for breast cancer is an important contributor to cancer outcomes and patient satisfaction. This study sought to define a patient-centered wait time by measuring the time from the first abnormal imaging to definitive surgery. The authors hypothesized that multiple preoperative investigations significantly increase the patient-centered wait time.

Methods

A retrospective analysis of prospectively maintained databases at the Institute for Clinical and Evaluative Sciences in Ontario, Canada was performed. Women undergoing primary surgery for invasive breast cancer from 2003 to 2011 were evaluated. The median wait time between the first abnormal imaging and definitive surgery was calculated. Uni- and multivariable analyses were performed to identify characteristics of the patients, treating institution, and diagnostic pathway that contribute significantly to the patient-centered wait time.

Results

Our final cohort consisted of 42,179 patients: 31,837 (75 %) who had breast conserving surgery and 10,342 (25 %) who underwent mastectomy. The median wait time from the first abnormal imaging to definitive surgery was 52 days (intraquartile range 35–76 days). In adjusted analysis, older patient age, later year of surgery, additional preoperative imaging, and biopsies beyond those required for diagnosis significantly and independently extended the surgical wait time. Preoperative consultations and institutional factors such as volume of breast surgery performed and geographic location also independently had an impact on surgical wait time.

Conclusions

This study defined a novel patient-centered measure of surgical wait time that more fully embraces the wait experienced by the patient. Many common preoperative interventions had a significant impact on overall wait time experienced by the patient. Evidence-based quality initiatives to coordinate appropriate investigations are needed to reduce wait times.

Keywords

Wait Time Income Quintile Average Wait Time Diagnostic Pathway Ontario Health Insurance Plan 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgment

The authors thank Mr. Refik Saskin and Mr. Jagadish Rangrej for their assistance with the statistical analysis.

Disclosure

Drs. Cordeiro, Dixon, Coburn and Holloway have no financial affiliations to disclose.

References

  1. 1.
    World Health Organization. GLOBOCAN 2012: estimated cancer incidence, mortality, and prevalence worldwide in 2012.Updated 2014. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed 25 March 2014.
  2. 2.
    Balduzzi A, Leonardi MC, Cardillo A, et al. Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy. Cancer Treat Rev. 2010;36:443–50.PubMedCrossRefGoogle Scholar
  3. 3.
    Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353:1119–26.PubMedCrossRefGoogle Scholar
  4. 4.
    Shin DW, Cho J, Kim SY, et al. Delay to curative surgery greater than 12 weeks is associated with increased mortality in patients with colorectal and breast cancer but not lung or thyroid cancer. Ann Surg Oncol. 2013;20:2468–76.PubMedCrossRefGoogle Scholar
  5. 5.
    Smith EC, Ziogas A, Anton-Culver H. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg. 2013;148:516–23.PubMedCrossRefGoogle Scholar
  6. 6.
    Vujovic O, Yu E, Cherian A, et al. Effect of interval to definitive breast surgery on clinical presentation and survival in early-stage invasive breast cancer. Int J Radiat Oncol Biol Phys. 2009;75:771–4.PubMedCrossRefGoogle Scholar
  7. 7.
    Dickerson SS, Alqaissi N, Underhill M, Lally RM. Surviving the wait: defining support while awaiting breast cancer surgery. J Adv Nurs. 2011;67:1468–79.PubMedCrossRefGoogle Scholar
  8. 8.
    Drageset S, Lindstrom TC, Giske T, Underlid K. Being in suspense: women’s experiences awaiting breast cancer surgery. J Adv Nurs. 2011;67:1941–51.PubMedCrossRefGoogle Scholar
  9. 9.
    Cancer Care Ontario. Wait time targets. http://www.health.gov.on.ca/en/pro/programs/waittimes/surgery/target.aspx. Updated 2014. Accessed 10 April 2014.
  10. 10.
  11. 11.
    Bilimoria KY, Ko CY, Tomlinson JS, et al. Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011;253:779–85.PubMedCrossRefGoogle Scholar
  12. 12.
    Plotogea A, Chiarelli AM, Mirea L, et al. Factors associated with wait times across the breast cancer treatment pathway in ontario. Springerplus. 2013;2:388-1801-2-388. eCollection 2013.Google Scholar
  13. 13.
    Angarita FA, Acuna SA, Fonseca A, Crystal P, Escallon J. Impact of preoperative breast MRIs on timing of surgery and type of intervention in newly diagnosed breast cancer patients. Ann Surg Oncol. 2010;17(Suppl 3):273–9.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2014

Authors and Affiliations

  • Erin Cordeiro
    • 1
    • 4
  • Matthew Dixon
    • 2
  • Natalie Coburn
    • 3
  • Claire M. B. Holloway
    • 3
  1. 1.Department of SurgeryUniversity of TorontoTorontoCanada
  2. 2.Department of SurgeryMaimondes Medical CentreBrooklynUSA
  3. 3.Division of General Surgery, Sunnybrook Health Sciences Centre, Department of SurgeryUniveristy of TorontoTorontoCanada
  4. 4.OttawaCanada

Personalised recommendations